Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Low IgG avidity for Toxoplasma gondii in consecutive pregnancies
PDF (Portuguese (Brazil))

Keywords

Toxoplasma gondii
Gestational toxoplasmosis
Prenatal care
Medical records

How to Cite

Low IgG avidity for Toxoplasma gondii in consecutive pregnancies. (2025). Electronic Journal Collection Health, 25(5), e20664. https://doi.org/10.25248/reas.e20664.2025

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To present a clinical case of a pregnant woman who consistently showed low avidity IgG test results for Toxoplasma gondii in two consecutive pregnancies. Case details: G5P2A2, 41 years old, followed up in the High-Risk Prenatal Care due to serologies for T. gondii with IgM+/IgG+ and avidity test performed at 11 weeks of gestation, showing 49% avidity. She brought exams from the previous pregnancy that also showed serologies for T. gondii with IgM+/IgG+ and low IgG avidity (42%). The fetus was evaluated at the Fetal Medicine outpatient clinic and showed no ultrasonographic abnormalities. The pregnancy progressed to spontaneous vaginal delivery at 38 weeks, resulting in a healthy newborn. Final considerations: The importance of the avidity test in managing gestational toxoplasmosis and the diagnostic limitations when low avidity is present in isolation is noted. It is suggested to standardize effective medical records across health services to allow tracking the serological history of pregnant women, in addition to training professionals in clinical protocols, such as the Technical Note (NT) No 100/2022 do Ministry of Health, to avoid unnecessary treatments.

PDF (Portuguese (Brazil))

References

AHMED M, et al. Toxoplasmosis in pregnancy. Eur J Obstet Gynecol Reprod Biol., 2020; 255: 44-50.

BEDNORZ A, et al. Use of Electronic Medical Records (EMR) in Gerontology: Benefits, Considerations and a Promising Future. Clin Interv Aging., 2023; 18: 2171-2183.

BOLLANI L, et al. Congenital Toxoplasmosis: The State of the Art. Front Pediatr., 2022; 10: 894-573.

BRASIL. Ministério da Saúde. DataSUS. Avaliable: <https://datasus.saude.gov.br/informacoes-de-saude-tabnet/>. Acess: 10 de outubro de 2024.

BRASIL. Ministério da Saúde. Secretaria de Atenção Primária à Saúde. Departamento de Saúde Materno-Infantil. Coordenação Geral de Saúde Perinatal e Aleitamento Materno. NOTA TÉCNICA Nº 100/2022 - CGSPAM/DSMI/SAPS/MS, 2022. Avaliable: <https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/t/toxoplasmose/arquivos/diretriz-nacional-para-a-conduta-clinica-diagnostico-e-tratamento-da-toxoplasmose-adquirida-na-gestacao-e-toxoplasmose-congenita/view>. Acess: 5 de fevereiro de 2025.

BRITO RMM, et al. Genetic diversity of Toxoplasma gondii in South America: occurrence, immunity, and fate of infection. Parasit Vectors, 2023; 16: 461.

DUBEY JP, et al. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitology, 2021; 148: 1406-1416.

FELÍN MS, et al. Building Programs to Eradicate Toxoplasmosis Part II: Education. Curr Pediatr Rep., 2022; 10: 93-108.

GUNDESLIOGLU OO, et al. Congenital Toxoplasmosis and Long-term Outcomes. Turkiye Parazitol Derg., 2024; 48: 8-14.

HEDMAN K, ROUSSEAU SA. Measurement of avidity of specific IgG for verification of recent primary rubella. J Med Virol.,1989; 27: 288-92.

KODYM P, et al. Detection of persistent low IgG avidity-an interpretative problem in the diagnosis of acute toxoplasmosis. PLoS One, 2023; 18.

LOVE JS, et al. The Parallel Pandemic: Medical Misinformation and COVID-19: Primum non nocere. J Gen Intern Med., 2020; 35: 2435-2436.

MANDELBROT L, et al. Toxoplasmose pendant la grossesse: proposition actuelle de priseen charge pratique. Gynecol Obstet Fertil Senol., 2021; 49: 782-791.

MARGONATO FB, et al. Toxoplasmosis in pregnancy: diagnosis, treatment and the importance of clinical protocol. Rev. Bras. Saúde Matern. Infant., 2007; 7: 381-386.

MOSHONOV R, et al. Benefit versus risk of chromosomal microarray analysis performed in pregnancies with normal and positive prenatal screening results: A retrospective study. PLoS One, 2021; 16.

ONDURU OG, et al. Evaluation of the level of awareness of congenital toxoplasmosis and associated practices among pregnant women and health workers in Tanzania's Temeke district in Dar es Salaam. Afr Health Sci., 2019; 19: 3027-3037.

PIRES LB, et al. Infection of Mouse Neural Progenitor Cells by Toxoplasma gondii Reduces Proliferation, Migration, and Neuronal Differentiation in Vitro. Am J Pathol., 2023;193: 977-994.

ROBERT-GANGNEUX F, DARDÉ ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev., 2012; 25: 264-96.

TEIMOURI A, et al. Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy. J Clin Microbiol., 2020; 58.

TORK M, et al. Design and optimization of IgG avidity test for differentiating acute from chronic human toxoplasmosis: A systematic review and meta-analysis. Exp Parasitol., 2025; 268: 108883.

VARGAS-VILLAVICENCIO JA, et al. Anti-Toxoplasma gondii IgM Long Persistence: What Are the Underlying Mechanisms? Microorganisms, 2022; 10: 1659.

WHITE MD, et al. Selective host autophagy is induced during the intracellular parasite Toxoplasma gondii infection controlling amino acid levels. mSphere., 2024; 9.

ZHOU Y, et al. Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and more. PLoS Negl Trop Dis., 2024; 18.